Search clinical trials for: Higher Risk Myelodysplastic Syndrome
Total 51518 results
-
Remix TherapeuticsRecruitingAcute Myeloid Leukemia | Myelodysplastic Syndromes | Acute Myeloid Leukemia Refractory | Higher Risk Myelodysplastic SyndromesUnited States
-
AkesoRecruitingHigher-risk Myelodysplastic SyndromesUnited States, China
-
GluBio Therapeutics Inc.RecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
Anhui Provincial HospitalRecruitingMyelodysplastic SyndromesChina
-
Groupe Francophone des MyelodysplasiesBristol-Myers Squibb; AbbVieRecruitingUntreated Myelodysplastic SyndromeFrance
-
Chordia Therapeutics, Inc.TheradexRecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
TJ Biopharma Co., Ltd.Recruiting
-
M.D. Anderson Cancer CenterRecruitingMyelodysplastic Syndromes | Myeloproliferative Chronic Myelomonocytic LeukemiaUnited States
-
CelgeneRecruitingMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteUnited States, Australia, Spain, Canada, United Kingdom
-
Novartis PharmaceuticalsRecruitingMyelodysplastic Syndrome (MDS)United States
-
Syros PharmaceuticalsRecruitingMyelodysplastic SyndromesUnited States, Spain, Belgium, Israel, France, United Kingdom, Austria, Czechia, Italy, Poland, Canada, Hungary, Germany
-
CellCentric Ltd.RecruitingAcute Myeloid Leukemia | Multiple Myeloma | Non Hodgkin Lymphoma | Peripheral T Cell Lymphoma | Haematological Malignancy | Higher-risk Myelodysplastic SyndromeUnited Kingdom, United States, France, Sweden, Spain
-
Precigen, IncRecruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
University of UlmRecruitingAcute Myeloid Leukemia (AML) | Higher Risk Myelodysplastic Syndromes (MDS With Excess Blasts 2)Austria, Germany
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingHigh Risk Myelodysplastic SyndromeUnited States
-
Karyopharm Therapeutics IncActive, not recruitingAcute Myeloid Leukemia (AML) | Metastatic Colorectal Cancer (mCRC) | Metastatic Castration-Resistant Prostate Cancer (mCRPC) | Relapsed/Refractory Multiple Myeloma (RRMM) | Higher-Risk Myelodysplastic Syndrome (HR-MDS) | Newly Diagnosed Intermediate/High-Risk MDSUnited States, France, Canada, Spain, China
-
AmgenCompletedChronic Myelomonocytic Leukemia | Higher Risk Myelodysplastic SyndromeUnited States
-
TakedaTakeda Development Center Americas, Inc.Active, not recruitingLeukemia, Myeloid, Acute | Leukemia, Myelomonocytic, Chronic | Myelodysplastic SyndromeAustralia, United States, Canada, Spain, Belgium, France, Czechia, Italy, Korea, Republic of, Israel, Brazil, China, Germany, Turkey, Japan, Greece, Poland, United Kingdom, Russian Federation, Mexico
-
Novartis PharmaceuticalsWithdrawnAcute Myeloid Leukemia | Myelodysplastic Syndromes
-
Washington University School of MedicineJazz PharmaceuticalsActive, not recruitingMyelodysplastic SyndromesUnited States
-
National Cancer Institute (NCI)Active, not recruitingChronic Myelomonocytic Leukemia | Myelodysplastic Syndrome | Myelodysplastic Syndrome With Excess Blasts | Chronic Myelomonocytic Leukemia-1 | Chronic Myelomonocytic Leukemia-2 | Myelodysplastic Syndrome With Excess Blasts-1 | Myelodysplastic Syndrome/Acute Myeloid LeukemiaCanada, United States
-
AbbVieGenentech, Inc.Active, not recruitingMyelodysplastic Syndrome (MDS)United States, Australia, Austria, Belgium, Brazil, Canada, China, Czechia, France, Germany, Hungary, Israel, Italy, Japan, Korea, Republic of, Netherlands, Poland, Puerto Rico, Russian Federation, Spain, Taiwan, Turkey, United Kingdom
-
Aptose Biosciences Inc.Active, not recruitingAcute Myeloid Leukemia | Myelodysplastic SyndromesUnited States
-
3D MedicinesActive, not recruitingMultiple Myeloma | Non-Hodgkin Lymphoma | Acute Leukemia | Higher-risk Myelodysplastic SyndromeChina
-
Astellas Pharma Global Development, Inc.CompletedMyelodysplastic Syndrome | Acute Myeloid Leukemia (AML)United States, Japan
-
Race Oncology LtdAstex Pharmaceuticals, Inc.WithdrawnAcute Myeloid Leukemia | Chronic Myelomonocytic Leukemia | Recurrent Acute Myeloid Leukemia | Refractory Acute Myeloid Leukemia | Higher Risk Myelodysplastic SyndromeAustralia
-
CelgeneActive, not recruitingMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteFrance, United States, Canada, Norway, Spain, United Kingdom
-
ALX Oncology Inc.Active, not recruitingHigher Risk Myelodysplastic SyndromesKorea, Republic of, United States, Spain
-
Masonic Cancer Center, University of MinnesotaCompletedAcute Myeloid Leukemia | Higher Risk Myelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRecurrent Acute Myeloid Leukemia | Recurrent Chronic Myelomonocytic Leukemia | Recurrent Myelodysplastic Syndrome | Refractory Acute Myeloid Leukemia | Refractory Chronic Myelomonocytic Leukemia | Refractory Myelodysplastic SyndromeUnited States
-
CelgeneCompletedMyelodysplastic Syndromes | Leukemia, Myeloid, AcuteCanada, Spain, United Kingdom, United States, France, Austria, Germany, Italy, Netherlands, Belgium, Portugal, Poland
-
Innovent Biologics (Suzhou) Co. Ltd.SuspendedMyelodysplastic SyndromesChina
-
AbbVieGenentech, Inc.Active, not recruitingMyelodysplastic Syndromes (MDS)United States, Australia, Canada, France, Germany, Italy, United Kingdom
-
Brian JonasPharmacyclics LLC.CompletedChronic Myelomonocytic Leukemia | Previously Treated Myelodysplastic Syndrome | Secondary Myelodysplastic Syndrome | de Novo Myelodysplastic Syndrome | Refractory Anemia With Excess Blasts in TransformationUnited States
-
TakedaNo longer available
-
Millennium Pharmaceuticals, Inc.CompletedMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Leukemia, Myelomonocytic, ChronicUnited States, Israel, Spain, France, Ireland, Canada, Germany, Czechia, Italy, Netherlands, Belgium, Bulgaria
-
Groupe Francophone des MyelodysplasiesCompleted
-
Janssen Research & Development, LLCargenxWithdrawnMyelodysplastic Syndromes | Leukemia, Myelomonocytic, ChronicUnited Kingdom, Switzerland, Italy, Germany, France, Spain, Australia, Turkey, Brazil, Russian Federation, Saudi Arabia
-
Yale UniversityWithdrawn
-
TakedaWithdrawn
-
M.D. Anderson Cancer CenterTeva Pharmaceuticals USACompleted
-
CelgeneCompletedMyelodysplastic SyndromesTaiwan
-
Groupe Francophone des MyelodysplasiesMerck Sharp & Dohme LLCTerminated
-
Masonic Cancer Center, University of MinnesotaMayo ClinicCompletedMyelodysplastic SyndromeUnited States
-
CelgeneCompletedMyelodysplastic Syndrome (MDS)China
-
Assistance Publique - Hôpitaux de ParisUnknown
-
Seagen Inc.TerminatedMyelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterGenzyme, a Sanofi CompanyCompletedMyelodysplastic SyndromeUnited States
-
M.D. Anderson Cancer CenterCompletedLeukemia | Myeloproliferative DiseasesUnited States
-
Sunnybrook Health Sciences CentreNovartisTerminatedMyelodysplastic SyndromesCanada